<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591351/" ref="ordinalpos=823&amp;ncbi_uid=4713950&amp;link_uid=PMC3591351" image-link="/pmc/articles/PMC3591351/figure/pone-0058355-g006/" class="imagepopup">Figure 6. ON01210.Na treatment in combination with radiation alters the MAPK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: ON01210.Na (Ex-RADÂ®) Mitigates Radiation Damage through Activation of the AKT <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Human Phospho-MAPK antibody arrays were treated with lysates from HFL-1 cells that were pre-treated with Vehicle (A), 20<b></b>uM ON01210.Na (B), Vehicle plus 10 Gy radiation (C), 20<b></b>uM ON01210.Na plus 10 Gy radiation (D). ON01210.Na treatment in combination with radiation increased the phosphorylation status of proteins associated with the AKT pathway.</div></div>